Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

PARPi-FL and Fluorescence Imaging in Detecting Cancer in Patients with Oral Cancer

Trial Status: temporarily closed to accrual

This phase I/II trial studies the side effects of and best dose of boron-dipyrromethene-modified olaparib fluorescent imaging agent (PARPi-FL) and fluorescence imaging in detecting cancer in patients with oral cancer. PARPi-FL may help surgeons detect cancer of the mouth and tongue, and make it easier for the surgeon to determine the location and size of the cancer.